Your browser doesn't support javascript.
loading
SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy.
Koukourakis, Michael I; Giatromanolaki, Alexandra; Fylaktakidou, Konstantina; Sivridis, Efthimios; Zois, Christos E; Kalamida, Dimitra; Mitrakas, Achilleas; Pouliliou, Stamatia; Karagounis, Ilias V; Simopoulos, Konstantinos; Ferguson, David J P; Harris, Adrian L.
Afiliação
  • Koukourakis MI; Department of Radiotherapy/Oncology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece. targ@her.forthnet.gr.
  • Giatromanolaki A; Department of Pathology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Fylaktakidou K; Department of Molecular Biology and Genetics, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Sivridis E; Department of Pathology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Zois CE; CR UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, UK.
  • Kalamida D; Department of Radiotherapy/Oncology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Mitrakas A; Department of Radiotherapy/Oncology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Pouliliou S; Department of Radiotherapy/Oncology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Karagounis IV; Department of Radiotherapy/Oncology, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Simopoulos K; Department of Experimental Surgery, Democritus University of Thrace / University General Hospital of Alexandroupolis, 68100, Alexandroupolis, Greece.
  • Ferguson DJP; CR UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, UK.
  • Harris AL; CR UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, UK.
Invest New Drugs ; 36(5): 773-781, 2018 10.
Article em En | MEDLINE | ID: mdl-29387992
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Protetores contra Radiação / Autofagia / Medula Óssea / Compostos Alílicos / Fígado Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Protetores contra Radiação / Autofagia / Medula Óssea / Compostos Alílicos / Fígado Idioma: En Ano de publicação: 2018 Tipo de documento: Article